儿童内脏动脉闭塞性疾病的动脉重建治疗
回顾性分析1992至2017年密歇根大学30例因内脏动脉闭塞性疾病手术的儿童,其中14例有症状性肠缺血,16例无症状行预防性重建;两组均无围手术期死亡,有症状组辅助通畅率93%且症状均缓解。
要点
- 儿童内脏动脉闭塞病变常合并腹主动脉缩窄(19例)或肾动脉开口狭窄(25例)。
- 有症状组14例均存在餐后腹部不适,7例因复发症状接受二次干预,辅助通畅率93%。
- 无症状组16例行预防性重建,无重大围手术期并发症,术后均无症状且无需二次内脏动脉干预。
核心结论
- 儿童内脏动脉闭塞性病变常与发育性主动脉和肾动脉闭塞性疾病相关;对有症状或无症状的儿童,审慎进行治疗性和预防性重建手术是合适的。
研究设计与样本
- 回顾性分析1992年至2017年在密歇根大学连续接受内脏动脉闭塞性疾病手术的30例儿童(18例男孩和12例女孩,年龄1.5至16岁,平均7.5±4.1岁)的临床过程。
主要发现
- 孤立性内脏动脉疾病不常见(2例),更多合并腹主动脉缩窄(19例)或肾动脉开口狭窄(25例)。
- 30例初次内脏动脉重建包括:肠系膜上动脉(SMA)主动脉再植入15例、腹腔肠系膜动脉干主动脉再植入2例、主动脉-腹腔动脉和主动脉-肠系膜动脉旁路7例、腹腔动脉再植入作为覆盖狭窄SMA开口的补片3例、腹腔动脉补片血管成形2例、SMA补片血管成形1例。
- 有症状组(I组,14例)表现为慢性餐后腹部不适(14例)、缺血相关肠道出血(2例)或发育迟缓(4例)的不同组合;其中4例在既往因肾血管性高血压接受干预时未处理已知的腹腔动脉和SMA闭塞病变,之后出现症状。
- I组6例儿童因复发症状接受7次二次再干预;仅发生1例重大围手术期并发症(节段性结肠梗死);重建动脉辅助通畅率为93%,所有儿童肠缺血症状均缓解;最近一次内脏动脉重建后平均随访4.3年。
- 无症状组(II组,16例)在联合主动脉和肾动脉手术(11例)、孤立腹主动脉重建(3例)或单独肾动脉重建(2例)的同时接受预防性内脏动脉重建;无重大围手术期并发症,术后均无症状,无需二次内脏动脉干预;平均随访7.4年。
临床怎么用
- 作者认为,对有症状或无症状的儿童内脏动脉闭塞性疾病,审慎进行治疗性和预防性重建手术是合适的。
- 本研究中心对合并主动脉和肾动脉病变的儿童,在行主动脉和/或肾动脉手术时同期行预防性内脏动脉重建。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pediatric splanchnic arterial occlusive disease is uncommon and a rare cause of clinically relevant intestinal ischemia. This study was undertaken to better define the clinical manifestations and appropriate treatment of celiac artery (CA) and superior mesenteric artery (SMA) occlusive disease in children. METHODS: Clinical courses of 30 consecutive children undergoing operations for splanchnic arterial occlusive disease at the University of Michigan from 1992 to 2017 were retrospectively analyzed. RESULTS: Vascular reconstructions were performed for splanchnic arterial disease in 18 boys and 12 girls, 1.5 to 16 years of age (mean, 7.5 ± 4.1 years). Isolated splanchnic arterial disease was uncommon (2 children), being more often associated with abdominal aortic coarctations (19 children) or ostial renal artery stenoses (25 children). Primary splanchnic arterial reconstructions (30) included aortic reimplantation of SMAs (15) or celiacomesenteric arteries (2), aortoceliac and aortomesenteric bypasses (7), reimplantation of the CA as a patch over the stenotic SMA orifice (3), and patch angioplasty of the CA (2) or SMA (1). There was no perioperative mortality. Two groups (I and II) were identified for study. Group I children (14) experienced symptomatic intestinal ischemia, manifested by various combinations of chronic postprandial abdominal discomfort (14), ischemia-related intestinal bleeding (2), or failure to thrive (4). Four children in group I became symptomatic after known CA and SMA occlusive disease was left untreated at the time they underwent earlier interventions for renovascular hypertension. Seven secondary redo interventions were undertaken for recurrent symptoms in six group I children. Only one major periprocedural complication occurred: segmental colon infarction. The assisted patency rate of reconstructed arteries in group I children was 93%, and intestinal ischemic symptoms resolved in every child. Group I follow-up from the most recent splanchnic arterial reconstruction averaged 4.3 years. Group II children (16) without manifestations of intestinal ischemia underwent prophylactic splanchnic arterial reconstructions in concert with combined aortic and renal artery procedures (11), isolated abdominal aortic reconstructions (3), or renal artery reconstructions alone (2). Group II children experienced no major perioperative morbidity and remained asymptomatic postoperatively, and none required secondary splanchnic artery interventions. Group II follow-up averaged 7.4 years. CONCLUSIONS: Pediatric splanchnic artery occlusive lesions are often associated with developmental aortic and renal artery occlusive disease. Carefully conducted therapeutic and prophylactic reconstructive procedures are appropriate in children having splanchnic arterial occlusive disease.
引用
- Coleman DM, Eliason JL, Stanley JC, et al. Arterial reconstructions for pediatric splanchnic artery occlusive disease. J Vasc Surg. 2018. PMID: 29622358. doi:10.1016/j.jvs.2017.12.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。